R Street’s Harm Reduction program aims for integrated harm reduction with tobacco, opioid and sexual behavior as central elements. We believe that “abstinence only” approaches to risky behaviors will not work on a population-wide basis. As such, we emphasize harm-reduction approaches that accept that harmful behavior may continue even as we seek to mitigate – if not eliminate – the harms involved.
Harm Reduction
The Issue
Publications
Review of: Nick Kerman, et al., “‘It’s not just injecting drugs’: Supervised consumption sites and the social determinants of health,” Drug and Alcohol Dependence 213 (Aug. 1, 2020), p….
Likely lawsuit isn’t main flaw with Missoula’s vaping ban
Steven Greenhut
To its credit, the Missoula City Council has taken extra steps to assure that its proposed ban on the sale of flavored-tobacco products conforms to state law, which limits the power of…
Dear City Council,
I am writing in regard to Missoula’s proposed ordinance, which would ban the sale of flavored-tobacco products, including most vaping products. I am the Western region…
Anti-Science War on Vaping
Alec Ulasevich
From RealClearHealth:
Vaping bans and politicized attacks on vaping devices hurt those who want to kick the smoking habit.
In the Age of the Internet, State Regulation of Consumer Products is Almost Impossible
Eli Lehrer
When it suits them, nearly all politicians say they support letting states make their own decisions. Take, for example, Sen. Minority Leader Chuck Schumer (D-NY) who has stood for increased federal…
Dear Suffolk County Legislators,
The R Street Institute is a national think tank devoted to free markets and limited, effective government. We are liberty-minded and non-partisan. As an…
WASHINGTON (Oct. 5, 2020)—The United Kingdom (UK) and Thailand are two countries that are often praised for their tobacco regulation. However, the way the two countries approach novel tobacco…
The United Kingdom’s approach to cessation which endorses harm reduction through the use of safer alternatives to combustible cigarettes stands in contrast to the Thailand policy of banning…
Review of: Tom P Freeman et al., “Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial,” The Lancet…